NCT04558307 - Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations | Biotech Hunter

Enrollment

1,000

Participants

Timeline

Start Date

June 3, 2020

Primary Completion Date

June 1, 2021

Study Completion Date

June 1, 2021

Conditions

Coronavirus Disease (COVID-19)

Interventions

DIAGNOSTIC_TEST

Pilot a rapid SARS-CoV-2 testing strategy

Rapid testing strategy at an FQHC using Mayo Clinic Laboratory (MCL) diagnostic processing with a real-time polymerase chain reaction assay for SARS-CoV-2 and a Mayo Clinic drive-through collection protocol.

OTHER

Community-driven messages to promote COVID-19 testing

A one-time communication about the availability of COVID-19 testing at the FQHC to patients randomized to the intervention group using any available means of communication (text and/or mailed letter).

Trial Locations (1)

55905

Mayo Clinic, Rochester